Clinical Trial Update: Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection [Phase 2]

View source ↗

Summary

Phase 2 safety assessment of elvitegravir boosted with ritonavir (EVG+RTV) when used with other antiretroviral agents for HIV-1 infection. The update reports sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ritonavir (Ritonavir)
• elvitegravir (elvitegravir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-04-25